Quibim Extends Into US Market With FDA Authorization Of QP-Prostate CAD
AI Radiology Tool For Prostate Cancer Lesion Detection
The US FDA's clearance of QP-Prostate CAD positions the company to support US health care providers and growing markets for fusion biopsy and focal therapy, said Quibim CEO and founder Angel Alberich-Bayarri.
